Literature DB >> 8945532

Burkholderia pseudomallei activates complement and is ingested but not killed by polymorphonuclear leukocytes.

A M Egan1, D L Gordon.   

Abstract

The mechanism by which Burkholderia pseudomallei is resistant to lysis by human serum is unknown but may include interference with complement activation, effective opsonization, or complement-mediated lysis. We investigated the interaction of B. pseudomallei with complement in the presence and absence of specific antibody to determine potential mechanisms of serum resistance. We demonstrated rapid activation and consumption of complement by B. pseudomallei which, in the absence of specific antibody, occurred predominantly via the alternative pathway. Complement activation was associated with deposition of the opsonically active C3b and iC3b fragments on the bacterial surface. C5b-9, detected on the bacterial surface after opsonic periods of 1 to 60 min, was susceptible to elution by 1 M NaCl, indicating that resistance to complement-mediated lysis may result from deposition of the membrane attack complex in a nonmicrobicidal location. To define the role of opsonins, we investigated the ability of polymorphonuclear leukocytes (PMNL) to phagocytose B. pseudomallei. Phagocytosis of bacteria by PMNL, and the observed oxidative response, was significantly increased by opsonization of organisms with complement and/or specific antibody. Despite opsonophagocytosis by PMNL and the production of an oxidative response, no significant bacterial killing was observed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8945532      PMCID: PMC174474          DOI: 10.1128/iai.64.12.4952-4959.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Mechanism of YadA-mediated serum resistance of Yersinia enterocolitica serotype O3.

Authors:  D Pilz; T Vocke; J Heesemann; V Brade
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

Review 2.  Complement evasion by bacteria and parasites.

Authors:  K A Joiner
Journal:  Annu Rev Microbiol       Date:  1988       Impact factor: 15.500

3.  Evidence for an ester linkage between the labile binding site of C3b and receptive surfaces.

Authors:  S K Law; N A Lichtenberg; R P Levine
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

4.  Kinetics of staphylococcal opsonization, attachment, ingestion and killing by human polymorphonuclear leukocytes: a quantitative assay using [3H]thymidine labeled bacteria.

Authors:  J Verhoef; P K Peterson; P G Quie
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

5.  Intracellular survival of Burkholderia pseudomallei.

Authors:  A L Jones; T J Beveridge; D E Woods
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

6.  Interaction of insulin with Pseudomonas pseudomallei.

Authors:  D E Woods; A L Jones; P J Hill
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

7.  Roles of complement and complement receptor type 3 in phagocytosis of Listeria monocytogenes by inflammatory mouse peritoneal macrophages.

Authors:  D A Drevets; P A Campbell
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

8.  Relapse in melioidosis: incidence and risk factors.

Authors:  W Chaowagul; Y Suputtamongkol; D A Dance; A Rajchanuvong; J Pattara-arechachai; N J White
Journal:  J Infect Dis       Date:  1993-11       Impact factor: 5.226

9.  The prevalence of human melioidosis in Northern Queensland.

Authors:  L R Ashdown; R W Guard
Journal:  Am J Trop Med Hyg       Date:  1984-05       Impact factor: 2.345

10.  Enzyme-linked immunosorbent assay for the diagnosis of clinical and subclinical melioidosis.

Authors:  L R Ashdown; R W Johnson; J M Koehler; C A Cooney
Journal:  J Infect Dis       Date:  1989-08       Impact factor: 5.226

View more
  33 in total

1.  Adherence of Burkholderia pseudomallei cells to cultured human epithelial cell lines is regulated by growth temperature.

Authors:  Nat F Brown; Justin A Boddey; Cameron P Flegg; Ifor R Beacham
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

2.  Humoral and cell-mediated adaptive immune responses are required for protection against Burkholderia pseudomallei challenge and bacterial clearance postinfection.

Authors:  Gareth D Healey; Stephen J Elvin; Margaret Morton; E Diane Williamson
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  Fate of a Burkholderia pseudomallei lipopolysaccharide mutant in the mouse macrophage cell line RAW 264.7: possible role for the O-antigenic polysaccharide moiety of lipopolysaccharide in internalization and intracellular survival.

Authors:  S Arjcharoen; C Wikraiphat; M Pudla; K Limposuwan; D E Woods; S Sirisinha; P Utaisincharoen
Journal:  Infect Immun       Date:  2007-06-18       Impact factor: 3.441

4.  Cationic liposomes extend the immunostimulatory effect of CpG oligodeoxynucleotide against Burkholderia pseudomallei infection in BALB/c mice.

Authors:  Apichaya Puangpetch; Robert Anderson; Yan Y Huang; Rasana W Sermswan; Wanpen Chaicumpa; Stitaya Sirisinha; Surasakdi Wongratanacheewin
Journal:  Clin Vaccine Immunol       Date:  2012-03-21

5.  Modified virulence of antibiotic-induced Burkholderia pseudomallei filaments.

Authors:  Kang Chen; Guang Wen Sun; Kim Lee Chua; Yunn-Hwen Gan
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

6.  Deletion of wboA enhances activation of the lectin pathway of complement in Brucella abortus and Brucella melitensis.

Authors:  C M Fernandez-Prada; M Nikolich; R Vemulapalli; N Sriranganathan; S M Boyle; G G Schurig; T L Hadfield; D L Hoover
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

Review 7.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

8.  The capsular polysaccharide of Burkholderia pseudomallei contributes to survival in serum by reducing complement factor C3b deposition.

Authors:  Shauna L Reckseidler-Zenteno; Rebekah DeVinney; Donald E Woods
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

9.  Human polymorphonuclear neutrophil responses to Burkholderia pseudomallei in healthy and diabetic subjects.

Authors:  Sujin Chanchamroen; Chidchamai Kewcharoenwong; Wattanachai Susaengrat; Manabu Ato; Ganjana Lertmemongkolchai
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

10.  Hepatitis C virus suppresses C9 complement synthesis and impairs membrane attack complex function.

Authors:  Hangeun Kim; Keith Meyer; Adrian M Di Bisceglie; Ranjit Ray
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.